Nunzia Pharmaceutical Beta vs. Market Capitalization

NUNZ Stock  USD 0  0.00  0.00%   
Taking into consideration Nunzia Pharmaceutical's profitability measurements, Nunzia Pharmaceutical may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Nunzia Pharmaceutical's ability to earn profits and add value for shareholders.
For Nunzia Pharmaceutical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Nunzia Pharmaceutical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Nunzia Pharmaceutical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Nunzia Pharmaceutical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Nunzia Pharmaceutical over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
Please note, there is a significant difference between Nunzia Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nunzia Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nunzia Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Nunzia Pharmaceutical Market Capitalization vs. Beta Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Nunzia Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Nunzia Pharmaceutical value to that of its competitors to determine the firm's financial worth.
Nunzia Pharmaceutical is regarded fourth in beta category among its peers. It is regarded second in market capitalization category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nunzia Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nunzia Pharmaceutical's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Nunzia Market Capitalization vs. Beta

Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Nunzia Pharmaceutical

Beta

 = 

Covariance

Variance

 = 
-2.57
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Nunzia Pharmaceutical

Market Cap

 = 

Shares Outstanding

X

Share Price

 = 
24.88 M
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.

Nunzia Market Capitalization vs Competition

Nunzia Pharmaceutical is regarded second in market capitalization category among its peers. Market capitalization of Drug Manufacturers—Specialty & Generic industry is now estimated at about 205.57 Million. Nunzia Pharmaceutical retains roughly 24.88 Million in market capitalization claiming about 12% of equities under Drug Manufacturers—Specialty & Generic industry.
Capitalization  Workforce  Revenue  Valuation  Total debt

Beta Analysis

As returns on the market increase, returns on owning Nunzia Pharmaceutical are expected to decrease by larger amounts. On the other hand, during market turmoil, Nunzia Pharmaceutical is expected to outperform it.

Nunzia Pharmaceutical Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Nunzia Pharmaceutical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Nunzia Pharmaceutical will eventually generate negative long term returns. The profitability progress is the general direction of Nunzia Pharmaceutical's change in net profit over the period of time. It can combine multiple indicators of Nunzia Pharmaceutical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. Nunzia Pharmaceutical Company was incorporated in 1986 and is based in Long Beach, California. Nunzia Pharmaceutical is traded on OTC Exchange in the United States.

Nunzia Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Nunzia Pharmaceutical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Nunzia Pharmaceutical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Nunzia Pharmaceutical's important profitability drivers and their relationship over time.

Use Nunzia Pharmaceutical in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nunzia Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nunzia Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.

Nunzia Pharmaceutical Pair Trading

Nunzia Pharmaceutical Pair Trading Analysis

The ability to find closely correlated positions to Nunzia Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nunzia Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nunzia Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nunzia Pharmaceutical to buy it.
The correlation of Nunzia Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nunzia Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nunzia Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nunzia Pharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Nunzia Pharmaceutical position

In addition to having Nunzia Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run IT Thematic Idea Now

IT
IT Theme
Information Technology (IT) companies and IT service providers across different domains. The IT theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize IT Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Nunzia Pink Sheet Analysis

When running Nunzia Pharmaceutical's price analysis, check to measure Nunzia Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nunzia Pharmaceutical is operating at the current time. Most of Nunzia Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Nunzia Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nunzia Pharmaceutical's price. Additionally, you may evaluate how the addition of Nunzia Pharmaceutical to your portfolios can decrease your overall portfolio volatility.